Cannabinoid Type 2 Receptor as a Target for Chronic - Pain

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|9|1|11-25

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.9, Iss.1, 2009-01, pp. : 11-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 3, 2010-09 ,pp. : 224-234

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid CB 1 receptor upregulation in a rat model of chronic neuropathic pain

By Siegling A.   Hofmann H.A.   Denzer D.   Mauler F.   De Vry J.  

European Journal of Pharmacology, Vol. 415, Iss. 1, 2001-03 ,pp. : 5-7

Elsevier

Access to resources Recommend Favorite

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration

By  

Current Neuropharmacology, Vol. 5, Iss. 2, 2007-06 ,pp. : 73-80

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 35, 2014-11 ,pp. : 4046-4058

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of the Cannabinoid CB2 Receptor in Pain Transmission and Therapeutic Potential of Small Molecule CB2 Receptor Agonists

By  

Current Medicinal Chemistry, Vol. 14, Iss. 8, 2007-04 ,pp. : 917-936

Bentham Science Publishers

Access to resources Recommend Favorite